Terumo BCT

34 articles about Terumo BCT

• 

  Biotech Movers and Shakers Aug 20

  8/20/2018

  This past week’s roundup of Movers and Shakers in the biotech industry started with a surprise. Gilead Science’s new(ish) chief medical officer was leaving the company six months after taking over the position.

• Be The Match BioTherapies Strengthens Business Development Team With New Hires

  6/28/2018

  Be The Match BioTherapies® today announced the appointment of Mark Flower as Vice President, Business Development and Strategic Partnerships, and Erin Rasch as Senior Director, Sales and New Business Development.

• Terumo BCT Selects Windchill Quality Management To Enhance Global Quality Processes

  10/10/2017

• Terumo BCT Joins CANCER-ID Consortium

  5/25/2017

• Terumo BCT Announces Enrollment Of The First Patient In Its U.S. Clinical Trial Designed To Study Platelets Treated With The Mirasol Pathogen Reduction Technology (PRT) System

  5/17/2017

• Cognate BioServices, Inc. Announces Strategic Collaboration With Terumo BCT

  10/3/2016

• Terumo BCT Announces A $17.4 Million Funding Contract From The Biomedical Advanced Research And Development Authority (BARDA)

  6/22/2016

• Terumo BCT Congratulates Innovative Clinicians With The 2015 Advancing Apheresis Award; Applications Open For 2016

  5/25/2016

• Angiocrine Bioscience Announces Collaboration For Clinical Cell Manufacturing Platform With Terumo BCT

  1/11/2016

• Terumo BCT Completes The First Clinical Study Reducing Malaria Transmission From Whole Blood Transfusions With Pathogen Reduction Technology

  10/27/2015

• Terumo BCT Announces Implementation Of Correct Connect System

  10/16/2015

• FDA Clears Seven-Day Platelet Storage And Wireless Capability For The Trima Accel System From Terumo BCT

  8/10/2015

• Applications Open For 2015 Terumo BCT Advancing Apheresis Award

  5/7/2015

• Terumo BCT Congratulates Two Recipients Of 2014 Advancing Apheresis Awards

  12/12/2014

• Terumo BCT And Banco de Sangre de Servicios Mutuos Unite In A Treatment Use Program Developed To Help Improve Blood Supply Safety Using An Investigational Device

  11/19/2014

• Terumo BCT And OneBlood Partner In A Treatment Use Program Of An Investigational Device To Help Improve Blood Supply Safety

  10/22/2014

• Terumo BCT Announces Collaboration To Evaluate Clinical Cell Production Using Quantum System

  8/7/2014

• Terumo BCT Opens $100 Million Manufacturing Facility In Vietnam, Building Will House 900+ Staffers

  7/18/2014

• Terumo BCT Enters Agreement With Kaneka Corporation

  5/20/2014

• Terumo BCT Launches Advancing Apheresis Award

  4/1/2014